565 related articles for article (PubMed ID: 30310258)
1. VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice.
Wang CS; Li WB; Wang HY; Ma YM; Zhao XH; Yang H; Qian JM; Li JN
World J Gastroenterol; 2018 Oct; 24(37):4254-4262. PubMed ID: 30310258
[TBL] [Abstract][Full Text] [Related]
2. Saccharomyces boulardii alleviates ulcerative colitis carcinogenesis in mice by reducing TNF-α and IL-6 levels and functions and by rebalancing intestinal microbiota.
Wang C; Li W; Wang H; Ma Y; Zhao X; Zhang X; Yang H; Qian J; Li J
BMC Microbiol; 2019 Nov; 19(1):246. PubMed ID: 31694526
[TBL] [Abstract][Full Text] [Related]
3. [Effect of VSL#3 and
Meng XC; Wang YN; Yan PG; Li YH; Wang HY; Qian JM; Li JN
Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(22):1735-1742. PubMed ID: 31216822
[No Abstract] [Full Text] [Related]
4. Structural shift of gut microbiota during chemo-preventive effects of epigallocatechin gallate on colorectal carcinogenesis in mice.
Wang X; Ye T; Chen WJ; Lv Y; Hao Z; Chen J; Zhao JY; Wang HP; Cai YK
World J Gastroenterol; 2017 Dec; 23(46):8128-8139. PubMed ID: 29290650
[TBL] [Abstract][Full Text] [Related]
5. Jianpi Qingchang decoction alleviates ulcerative colitis by inhibiting nuclear factor-κB activation.
Zheng L; Zhang YL; Dai YC; Chen X; Chen DL; Dai YT; Tang ZP
World J Gastroenterol; 2017 Feb; 23(7):1180-1188. PubMed ID: 28275298
[TBL] [Abstract][Full Text] [Related]
6. Suppression of colitis-associated carcinogenesis through modulation of IL-6/STAT3 pathway by balsalazide and VSL#3.
Do EJ; Hwang SW; Kim SY; Ryu YM; Cho EA; Chung EJ; Park S; Lee HJ; Byeon JS; Ye BD; Yang DH; Park SH; Yang SK; Kim JH; Myung SJ
J Gastroenterol Hepatol; 2016 Aug; 31(8):1453-61. PubMed ID: 26711554
[TBL] [Abstract][Full Text] [Related]
7. Effects of probiotics and prebiotics on intestinal microbiota in mice with acute colitis based on 16S rRNA gene sequencing.
Wang YN; Meng XC; Dong YF; Zhao XH; Qian JM; Wang HY; Li JN
Chin Med J (Engl); 2019 Aug; 132(15):1833-1842. PubMed ID: 31268903
[TBL] [Abstract][Full Text] [Related]
8. Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota.
Chen H; Ye C; Cai B; Zhang F; Wang X; Zhang J; Zhang Z; Guo Y; Yao Q
BMC Cancer; 2022 May; 22(1):566. PubMed ID: 35596224
[TBL] [Abstract][Full Text] [Related]
9. Microbiota modification by probiotic supplementation reduces colitis associated colon cancer in mice.
Mendes MCS; Paulino DS; Brambilla SR; Camargo JA; Persinoti GF; Carvalheira JBC
World J Gastroenterol; 2018 May; 24(18):1995-2008. PubMed ID: 29760543
[TBL] [Abstract][Full Text] [Related]
10. Probiotic administration alters the gut flora and attenuates colitis in mice administered dextran sodium sulfate.
Nanda Kumar NS; Balamurugan R; Jayakanthan K; Pulimood A; Pugazhendhi S; Ramakrishna BS
J Gastroenterol Hepatol; 2008 Dec; 23(12):1834-9. PubMed ID: 19120873
[TBL] [Abstract][Full Text] [Related]
11. Administration of Bifidobacterium bifidum CGMCC 15068 modulates gut microbiota and metabolome in azoxymethane (AOM)/dextran sulphate sodium (DSS)-induced colitis-associated colon cancer (CAC) in mice.
Wang Q; Wang K; Wu W; Lv L; Bian X; Yang L; Wang Q; Li Y; Ye J; Fang D; Wu J; Jiang X; Xie J; Lu Y; Li L
Appl Microbiol Biotechnol; 2020 Jul; 104(13):5915-5928. PubMed ID: 32367312
[TBL] [Abstract][Full Text] [Related]
12. Enteric Delivery of Regenerating Family Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in Mice With Colitis.
Darnaud M; Dos Santos A; Gonzalez P; Augui S; Lacoste C; Desterke C; De Hertogh G; Valentino E; Braun E; Zheng J; Boisgard R; Neut C; Dubuquoy L; Chiappini F; Samuel D; Lepage P; Guerrieri F; Doré J; Bréchot C; Moniaux N; Faivre J
Gastroenterology; 2018 Mar; 154(4):1009-1023.e14. PubMed ID: 29133078
[TBL] [Abstract][Full Text] [Related]
13. Baitouweng decoction alleviates dextran sulfate sodium-induced ulcerative colitis by regulating intestinal microbiota and the IL-6/STAT3 signaling pathway.
Xuan-Qing CHEN; Xiang-Yu LV; Shi-Jia LIU
J Ethnopharmacol; 2021 Jan; 265():113357. PubMed ID: 32891820
[TBL] [Abstract][Full Text] [Related]
14. Comparison of effects on colitis-associated tumorigenesis and gut microbiota in mice between Ophiocordyceps sinensis and Cordyceps militaris.
Ji Y; Tao T; Zhang J; Su A; Zhao L; Chen H; Hu Q
Phytomedicine; 2021 Sep; 90():153653. PubMed ID: 34330600
[TBL] [Abstract][Full Text] [Related]
15. Moxibustion treatment modulates the gut microbiota and immune function in a dextran sulphate sodium-induced colitis rat model.
Qi Q; Liu YN; Jin XM; Zhang LS; Wang C; Bao CH; Liu HR; Wu HG; Wang XM
World J Gastroenterol; 2018 Jul; 24(28):3130-3144. PubMed ID: 30065559
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of chronic ulcerative colitis-associated adenocarcinoma development in mice by VSL#3.
Talero E; Bolivar S; Ávila-Román J; Alcaide A; Fiorucci S; Motilva V
Inflamm Bowel Dis; 2015 May; 21(5):1027-37. PubMed ID: 25793324
[TBL] [Abstract][Full Text] [Related]
17. Beneficial effects resulting from oral administration of
Souza ELS; Campos CLV; Reis DC; Cassali GD; Generoso SV; Cardoso VN; Azevedo V; Medeiros JD; Fernandes GR; Nicoli JR; Martins FS
Benef Microbes; 2020 Dec; 11(8):779-790. PubMed ID: 33191778
[TBL] [Abstract][Full Text] [Related]
18. Pre-Administration of Berberine Exerts Chemopreventive Effects in AOM/DSS-Induced Colitis-Associated Carcinogenesis Mice via Modulating Inflammation and Intestinal Microbiota.
Deng J; Zhao L; Yuan X; Li Y; Shi J; Zhang H; Zhao Y; Han L; Wang H; Yan Y; Zhao H; Wang H; Zou F
Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215376
[TBL] [Abstract][Full Text] [Related]
19. Wallace melon juice fermented with Lactobacillus alleviates dextran sulfate sodium-induced ulcerative colitis in mice through modulating gut microbiota and the metabolism.
Zhang J; Zhong Y; Wang D; Zhu J; Deng Y; Li Y; Liu C; Wang JL; Zhang M
J Food Sci; 2024 Apr; 89(4):2450-2464. PubMed ID: 38462851
[TBL] [Abstract][Full Text] [Related]
20. Bifidobacterium longum and VSL#3
Chen X; Fu Y; Wang L; Qian W; Zheng F; Hou X
Dev Comp Immunol; 2019 Mar; 92():77-86. PubMed ID: 30227219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
